Elisa Gremese
Elisa Gremese
Verified email at unicatt.it
TitleCited byYear
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis
G Peluso, A Michelutti, S Bosello, E Gremese, B Tolusso, G Ferraccioli
Annals of the rheumatic diseases 70 (1), 172-175, 2011
1752011
Obesity and reduction of the response rate to anti–tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine
E Gremese, A Carletto, M Padovan, F Atzeni, B Raffeiner, AR Giardina, ...
Arthritis care & research 65 (1), 94-100, 2013
1392013
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the …
F Atzeni, P Sarzi-Puttini, C Botsios, A Carletto, P Cipriani, EG Favalli, ...
Autoimmunity reviews 12 (2), 225-229, 2012
1272012
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study
E Gremese, F Salaffi, SL Bosello, A Ciapetti, F Bobbio-Pallavicini, ...
Annals of the rheumatic diseases 72 (6), 858-862, 2013
1092013
Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis
G Ferraccioli, L Bracci-Laudiero, S Alivernini, E Gremese, B Tolusso, ...
Molecular medicine 16 (11), 552-557, 2010
1092010
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk
E Gremese, G Ferraccioli
Autoimmunity reviews 10 (10), 582-589, 2011
1022011
Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression
S Bosello, AL Fedele, G Peluso, E Gremese, B Tolusso, G Ferraccioli
Annals of the rheumatic diseases 70 (7), 1292-1295, 2011
942011
Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step‐up combination therapy (methotrexate, cyclosporin A, sulphasalazine …
GF Ferraccioli, E Gremese, P Tomietto, G Favret, R Damato, E Di Poi
Rheumatology 41 (8), 892-898, 2002
932002
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors
F Iannone, E Gremese, F Atzeni, D Biasi, C Botsios, P Cipriani, C Ferri, ...
The Journal of rheumatology 39 (6), 1179-1184, 2012
922012
IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy
B Tolusso, D Pietrapertosa, A Morelli, M De Santis, E Gremese, G Farina, ...
Future Medicine Ltd 7 (5), 683-695, 2006
802006
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis
E Gremese, S Bernardi, S Bonazza, M Nowik, G Peluso, A Massara, ...
Rheumatology 53 (5), 875-881, 2014
742014
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus
A Bortoluzzi, CA Scire, S Bombardieri, L Caniatti, F Conti, S De Vita, ...
Rheumatology 54 (5), 891-898, 2014
672014
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis
G Zizzo, M De Santis, SL Bosello, AL Fedele, G Peluso, E Gremese, ...
Clinical immunology 138 (1), 107-116, 2011
662011
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross …
M Govoni, S Bombardieri, A Bortoluzzi, L Caniatti, C Casu, F Conti, ...
Rheumatology 51 (1), 157-168, 2011
632011
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases)
E Gremese, B Tolusso, MR Gigante, G Ferraccioli
Frontiers in immunology 5, 576, 2014
602014
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry.
L Iaccarino, E Bartoloni, L Carli, F Ceccarelli, F Conti, SV De, G Ferraccioli, ...
Clinical and experimental rheumatology 33 (4), 449-456, 2015
592015
Validation of the classification criteria for cryoglobulinaemic vasculitis
L Quartuccio, M Isola, L Corazza, M Ramos-Casals, S Retamozo, ...
Rheumatology 53 (12), 2209-2213, 2014
522014
Benefit/risk of cyclosporine in rheumatoid arthritis
E Gremese, GF Ferraccioli
Clinical and experimental rheumatology 22, S101-S101, 2004
492004
PTPN22 1858C> T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis
MC Totaro, B Tolusso, V Napolioni, F Faustini, S Canestri, A Mannocci, ...
PLoS One 6 (9), e24292, 2011
472011
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy
R Caporali, F Conti, S Alivernini, F Atzeni, B Seriolo, M Cutolo, G Valesini, ...
Clin Exp Rheumatol 29 (3 Suppl 66), S7-14, 2011
45*2011
The system can't perform the operation now. Try again later.
Articles 1–20